Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 8/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9321905 | 0.92 | THRB (0.55) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL13950019 | 0.90 | THRB (0.53) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL331327 | 0.89 | TSHR (0.62) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL345245 | 0.89 | TSHR (0.62) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL16351315 | 0.89 | THRB (0.55) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL11138948 | 0.89 | TSHR (0.46) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL23530413 | 0.87 | TSHR (0.66) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL7892697 | 0.87 | TSHR (0.66) | TSHRTHRBALDH1A1PAOXPOLB | |
| SCHEMBL10874568 | 0.87 | THRB (0.72) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL110870 | 0.86 | THRB (0.55) | TSHRTHRBALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978220-A | Acid liquid gelatinizer and preparation method thereof | 中国石油天然气集团有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20060181587-A1 | Ink set and media for ink-jet printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2006-08-17 | — | — | US | claimed |
| US-4299911-A | POLYMER CONTAINING AN ETHYLENICALLY UNSATURATED DOUBLE BOND | SOMAR MANUFACTURING CO., LTD. (JP) | 1981-11-10 | — | — | US | claimed |
| US-20260022243-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | TECHNO UMG CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4603541-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | Techno-UMG Co., Ltd. (JP) | 2025-08-20 | — | — | EP | disclosed |
| CN-119978220-A | Acid liquid gelatinizer and preparation method thereof | 中国石油天然气集团有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119978220-A | Acid liquid gelatinizer and preparation method thereof | 中国石油天然气集团有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119731268-A | Thermoplastic resin composition and molded article | 大科能宇菱通株式会社 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024080062-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | テクノＵＭＧ株式会社 | 2024-04-18 | — | — | WO | disclosed |
| US-20240115741-A1 | LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-04-11 | — | — | US | disclosed |
| US-11866573-B2 | Thermoplastic resin composition and molded article | TECHNO-UMG CO., LTD. (JP) | 2024-01-09 | — | — | US | disclosed |
| WO-1998056592-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG INDUSTRIES OHIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056591-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG INDUSTRIES OHIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| US-5219909-A | Derived from reaction of 4-amino-1,2,4-triazole, an aliphatic diisocyanate and reduced sugar or glycerol; for polyurethanes and spandex | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-06-15 | — | — | US | disclosed |
| US-4336345-A | Composition comprising condensation cross-linkable novel methacrylate polymers | ROHM AND HAAS COMPANY (US) | 1982-06-22 | — | — | US | disclosed |
| US-4299911-A | POLYMER CONTAINING AN ETHYLENICALLY UNSATURATED DOUBLE BOND | SOMAR MANUFACTURING CO., LTD. (JP) | 1981-11-10 | — | — | US | disclosed |
| US-4226753-A | Novel methacrylic polymers having condensation-crosslinkable functionality | ROHM AND HAAS COMPANY (US) | 1980-10-07 | — | — | US | disclosed |
| US-4212782-A | Polymers of acid addition salts of methacrylic acid and a 2-mono(lower)alkylaminoethyl methacrylate | NORMAC, INC. (US) | 1980-07-15 | — | — | US | disclosed |
| US-4103093-A | CHAIN REGULATING ALCOHOL, ALKOXIDE CATALYST | ROHM AND HAAS COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-3950398-A | Methacrylic acid addition salt of 2-mono(lower)alkyl amino ethyl methacrylate | NORMAC, INC. (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115741-A1 | LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF | MSN, CD44, CD47 | TSHR 4300/4885THRB 4596/4885ALDH1A1 3614/4885 |
| US-20260022243-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | VMA21, VCP, VMP1 | TSHR 4425/4885THRB 2369/4885ALDH1A1 1858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.